Immunovia's CEO Mats Grahn sells 48,000 Immunovia shares to a Swedish institutional investor
· The buyer is an institutional investor · The transaction was carried out at a price of SEK 168 per share. · Mats Grahn has committed to new lock up restrictions of 12 months from today's date. Mats Grahn, CEO of Immunovia, today announced that he has sold 48,000 shares of Immunovia, corresponding to 11.6% of his holding in Immunovia. The shares have been sold at a price of SEK 168 per share. The buyer is a Swedish institutional investor. The reason for the sale is for private real estate business. With the transaction, Immunovia today announced a change in the company's